/ /

Ilya Petrou, M.D.
ECP may prevent mycosis fungoides progression
Extracorporeal photopheresis is underused for early-stage mycosis fungoides. ECP is capable of correcting the cytokine imbalance seen in patients with MF and results in an increase of Th1 cytokines. Clinicians should consider more frequent use in select patients
Unlock the right combination of generic, branded topical preparations to maximize efficacy
Contrary to popular belief, not all generic and branded topical preparations are created equal in terms of efficacy and tolerability, in part due to the crucial differences in the vehicle used.
Targeted treatment approaches optimize patient care
Some diseases, conditions and treatments are different in patients with skin of color as compared to Caucasian patients, and understanding these differences is essential in choosing appropriate therapy, according to Heather Woolery-Lloyd, M.D.
Deep shave biopsy remains efficient, useful technique
Although there is concern about a slight risk of under-staging caused by technique inaccuracy, benefits outweigh all of the risks when conducting a deep shave biopsy, says Mary H. Lien, M.D., department of dermatology & cutaneous surgery, University of South Florida College of Medicine and the H. Lee Moffitt Cancer Center, Tampa.
New therapies offer promise for cutaneous T-cell lymphoma
Some of the continuing challenges central to the management of cutaneous T-cell lymphoma (CTCL) include improving the survival and prognosis of patients, as well as helping to make proposed treatments more affordable and accessible, says Elise A. Olsen, M.D.
Belotero Balance appears to rival leading dermal fillers
Belotero Balance (Merz), one of the newer hyaluronic acid (HA) fillers, appears to rival other longer-standing dermal fillers in efficacy and safety, offering physicians and their patients a new treatment option for the Aesthetic correction of moderate-to-severe facial wrinkles and folds, says Derek H. Jones, M.D.
Newer chemotherapeutic agents bring concerns in patient care
The use of newer and more targeted chemotherapeutic agents can lead to atypical side effects affecting the skin, hair and nails of oncology patients, and these side effects can be different from those typically seen with longer-standing agents, says Beth N. McLellan, M.D., Ronald O. Perelman Department of Dermatology, New York University, New York.
Phototherapy remains viable option for treating psoriasis
Phototherapy remains viable option for treating psoriasis
In certain cases, phototherapy may be the treatment of choice for patients with psoriasis, surpassing the benefits of even biologics, says Herbert Hoenigsmann, M.D., professor of dermatology, emeritus chairman, department of dermatology, Medical University of Vienna.
Organ transplant recipients at much greater risk for skin cancer
Patients who undergo a solid organ transplant procedure have an alarmingly higher incidence of skin cancers compared to the general population. Special care and management strategies involving a multidisciplinary approach are warranted in this group, says Mich?l O'Donoghue, M.D., a dermatologist in private practice in Oak Brook, Ill.
Typical cutaneous malignancies can do not-so-typical things
A patient's immunodeficiency and/or sheer neglect of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) tumors can result in very large, difficult-to-resect lesions, begging the need for higher vigilance and closer patient care, said Robert E. Clark, M.D., Ph.D., of the Cary Skin Center, Cary, N.C., at the 2012 meeting of Mastering Advances in Dermatology: Beyond Skin Deep in April.


View Results